Patent · US Active

VEGF-binding fusion proteins and nucleic acids encoding the same

US7396664B2 · kind B2 · utility

109Cited by

1References

11Claims

0Family size

Assignee

REGENERON PHARMACEUTICALS, INC. · US

Inventors

Thomas Daly · New City, US
Nicholas J. Papadopoulos · Lagrangeville, US
Margaret Karow · Newbury Park, US

Key dates

Filing date	Aug 16, 2005
Grant date	Jul 8, 2008
Priority date	—
Expiry date	Jun 9, 2026

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Nucleic acid molecules and multimeric proteins capable of binding vascular endothelial growth factor (VEGF). VEGF traps are disclosed which are therapeutically useful for treating VEGF-associated conditions and diseases, and are specifically designed for local administration to specific organs, tissues, and/or cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.